Last updated September 29, 2026

Haptika

Developing body-worn electrical stimulation to support movement rehabilitation

Physical TherapyNeurotechWearables

and spinal cord injury can disrupt the nerve signals that control movement, leaving people with weakness and difficulty walking. Rehabilitation requires repeated, tailored practice, while continued access to specialist support and suitable equipment can be difficult outside the clinic.

Haptika is developing body-worn electrical stimulation to support movement rehabilitation. Its approach aims to help patients practise movement with adjustable stimulation and simple session controls, making therapy easier to fit into daily routines.

Key Investor Signals

Built a sensory-feedback prototype tested with users

The team built a functional prosthesis-feedback prototype with a pressure-sensing glove and vibrating armband, then tested the design directly with users during development.

Won Spain’s national James Dyson Award in 2025

The international engineering-design competition selected Haptika as Spain’s national winner for its non-invasive sensory-feedback system for upper-limb prosthesis users.

Won Santander X Spain’s university award in 2025

Banco Santander’s entrepreneurship competition awarded Haptika first place in its University category at Valencia Digital Summit, ahead of the other category finalists.

Team

Jordi Puig Prujà

CEO and Co-founder

  • Worked as a mechatronics engineer at ABLE Human Motion, developing rehabilitation devices including exoskeletons for people with impaired mobility.
  • Helped develop a prosthetic arm with CIMA 3D, taking the project to the international assistive-technology competition.
  • Trained in industrial electronics and completed ’s master’s in product design and development.

Albert Lladonosa Gort

CTO and Co-founder

  • Brings an engineering background in production, research and development, and the development of physical products.
  • Completed UPC School’s master’s in product design and development, with training focused on engineering physical products.
  • Completed a mechanical engineering degree at UPC

Product

Haptika’s current platform combines a body-worn stimulation module with a companion app. It uses to support movement practice, with an emphasis on gait recovery and controls for individual sessions and patient profiles.

Electrical movement support

The non-invasive module applies functional electrical stimulation during rehabilitation. Its modular, body-worn design is intended to adapt to different movement needs, with gait recovery as an explicit focus.

Stimulation timed to movement

The system is designed to synchronise stimulation with real movement during rehabilitation. Timing stimulation to active practice is intended to fit treatment into the patient’s rehabilitation routine.

App-based session management

The companion app provides session start controls, live status and adjustable intensity. Patient profiles and a progress history keep session information together as patients continue their rehabilitation.

Market Overview

Functional electrical stimulation equipment serves neurological rehabilitation, helping clinicians support movement after stroke or spinal cord injury. Buyers include rehabilitation providers and patients using prescribed devices at home. The category combines physical equipment with assessment, fitting and follow-up care.

Commercial suppliers serve both clinics and home users, while wireless systems reduce the burden of cables during movement. Purchasing routes vary by health system: UK services can use local funding or self-payment. Clinician-led setup and recurring support remain part of the device model, alongside hardware and consumables.

Global functional stimulation market
$672.8M

The global functional electrical stimulation market was estimated at $672.8 million in 2025.

Wireless share of stimulation sales
58.2%

Wireless systems were projected to account for 58.2% of global functional stimulation revenue in 2025.

Established rehabilitation-device sales
~$50M/year

Bioness’s advanced rehabilitation business represented about $50 million in annual revenue in its 2024 sale announcement.

People needing neurological rehabilitation
225.38M

An analysis published in 2026 estimated global neurological rehabilitation needs at 225.38 million people in 2021.

Comparable Outcomes

Movement stimulation

Bioness rehabilitation business

Acquired by Accelmed in 2024: $25M upfront plus up to $20M in earn-outs

Bioness’s advanced rehabilitation business supplied electrical stimulation, gait-training and therapy systems for people recovering from stroke and other neuromuscular conditions. Accelmed acquired the business from Bioventus in December 2024 for $25 million at closing, subject to adjustments, plus up to $20 million in performance-based earn-outs.

Interested in More Startups Like Haptika?

Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.

Get Deal Flow

Sources

This profile was built from public company materials, ecosystem sources, market references, and professional profiles.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.